Journal article
Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits
GL Murray, J Danielewski, CS Bradshaw, DA Williamson, J Birnie, JP Su, V De Petra, LY Tan, R Wee, DA MacHalek, TRH Read, SM Garland
Journal of Medical Microbiology | MICROBIOLOGY SOC | Published : 2020
DOI: 10.1099/jmm.0.001140
Abstract
Introduction. Mycoplasma genitalium is a sexually transmitted organism with high levels of resistance to the recommended first-line therapy, azithromycin. The ResistancePlus MG test concurrently detects M. genitalium, and the presence of macrolide-resistance mutations (MRM). European, UK and Australian guidelines recommend a diagnostic test that reports MRM to optimize treatment through resistance-guided therapy. Hence, for samples collected for use on other platforms, reflex testing using the ResistancePlus MG test would be beneficial. Aim. To validate the ResistancePlus MG assay using samples collected in Aptima buffer for testing on the Hologic Panther. Methodology. Positive (n=99) and ne..
View full abstractGrants
Awarded by Department of Industry, Innovation and Science, Australian Government
Funding Acknowledgements
This work was supported by the Department of Industry, Innovation and Science, The Australian Federal Government (Innovations Connections grant number ICG000220, jointly held with SpeeDx); the Department of Health, the State Government of Victoria (Victorian Medical Research Acceleration Fund, jointly held with SpeeDx), and The National Health and Medical Research Council of Australia early career fellowships for TRHR (1091536) and DAW (GNT1123854).